​

Cellectar Biosciences Ownership | Who Owns Cellectar Biosciences?

OverviewForecastFinancialsChartTranscripts

Cellectar Biosciences Ownership Summary

Cellectar Biosciences is owned by 0.09% institutional investors, 1.71% insiders, and 98.20% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of CLRB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.33% of its assets in Cellectar Biosciences shares.

CLRB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCellectar Biosciences0.09%1.71%98.20%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management---
Bfsg---
Commonwealth equity services---
Vanguard personalized indexing management---
Two sigma securities---
Sequoia financial advisors---
Eversource wealth advisors---
Baader bank aktiengesellschaft---
Two sigma investments, lp---
Commerce bank---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Bfsg---
Commonwealth equity services---
Vanguard personalized indexing management---
Two sigma securities---
Sequoia financial advisors---
Eversource wealth advisors---
Baader bank aktiengesellschaft---
Two sigma investments, lp---
Commerce bank---

Top Buyers

HolderShares% AssetsChange
Allsquare wealth management---18.00
Harbour investments---50.00
Jpmorgan chase---76.00
Us bancorp \de\---100.00
Enrich financial partners---102.00

Top Sellers

HolderShares% AssetsChange
Vanguard group---1.72M
Ubs group---920.35K
Geode capital management---443.42K
Squarepoint ops---370.87K
Blackrock funding, inc. /de---230.81K

Sold Out

HolderChange
Allsquare wealth management-18.00
Harbour investments-50.00
Jpmorgan chase-76.00
Us bancorp \de\-100.00
Enrich financial partners-102.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251-96.88%40,228-99.21%-0.05%--100.00%1-83.33%
Dec 31, 202432-13.51%5,096,844-63.61%131.10%1721.43%6-33.33%
Sep 30, 202437-7.50%14,004,95420.80%353.40%14-36.36%912.50%
Jun 30, 202440-21.57%11,593,73326.98%323.34%22-38.89%860.00%
Mar 31, 20245196.15%9,130,4256.12%311.46%36140.00%5-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.07M2.33%-
Vanguard Total Stock Mkt Idx Inv35.76K1.25%3.00
Vanguard Institutional Extnd Mkt Idx Tr18.99K0.66%29.00
Fidelity Extended Market Index7.60K0.27%-20.00
BlackRock Extended Equity Market K72.26K0.20%-31.00
Dimensional US Small Cap ETF4.60K0.16%-
iShares Micro-Cap ETF73.44K0.16%-
Extended Equity Market Fund K2.33K0.13%-48.00
Spartan Extended Market Index Pool E56.68K0.12%27.44K
NT Ext Equity Mkt Idx Fd - NL2.06K0.11%1.15K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 02, 2025CARUSO JAMES V Chief Executive OfficerBuy$52.50K
Jul 02, 2025CARUSO JAMES V Chief Executive OfficerBuy$49.90K
Jul 02, 2025Longcor Jarrod Chief Operating OfficerBuy$49.90K
Jul 02, 2025Longcor Jarrod Chief Operating OfficerBuy$52.50K
Jul 02, 2025Kolean Chad J Chief Financial OfficerBuy$24.95K

Insider Transactions Trends

DateBuySell
2025 Q36-
2025 Q11-
2024 Q2--
2023 Q4--
2023 Q2--

CLRB Ownership FAQ

Who Owns Cellectar Biosciences?

Cellectar Biosciences shareholders are primarily institutional investors at 0.09%, followed by 1.71% insiders and 98.20% retail investors. The average institutional ownership in Cellectar Biosciences's industry, Biotech Stocks , is 64.05%, which Cellectar Biosciences falls below.

Who owns the most shares of Cellectar Biosciences?

Cellectar Biosciences’s largest shareholders are Geode capital management (0 shares, 0%), Bfsg (0 shares, 0%), and Commonwealth equity services (0 shares, 0%). Together, they hold 0% of Cellectar Biosciences’s total shares outstanding.

Does Blackrock own Cellectar Biosciences?

BlackRock is not among the top 10 institutional shareholders of Cellectar Biosciences.

Who is Cellectar Biosciences’s biggest shareholder by percentage of total assets invested?

Geode capital management is Cellectar Biosciences’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Cellectar Biosciences shares, valued at 0$.

Who is the top mutual fund holder of Cellectar Biosciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cellectar Biosciences shares, with 2.33% of its total shares outstanding invested in 1.07M Cellectar Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools